Is GPCR or GRI more undervalued in 2026?

CirclFi compares Structure Therapeutics Inc. (GPCR) and GRI Bio, Inc. (GRI) using 13 institutional-grade valuation models. GPCR has a Quality of Company score of 4.1/10 while GRI scores 3.9/10.

Which is a better buy — GPCR or GRI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do GPCR and GRI valuations compare?

GPCR at $39.34 and GRI at $2.06 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

GPCR vs GRI Valuation Comparison 2026 — Intrinsic Value Analysis

GPCR

Pharmaceutical Preparations

Structure Therapeutics Inc.

Quality

4.1

out of 10

Value Trap

SAFE

Price

$39.34

Last close

Models

10/13

Active

GRI

Pharmaceutical Preparations

GRI Bio, Inc.

Quality

3.9

out of 10

Value Trap

SAFE

Price

$2.06

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	GPCR Fair Value	GPCR Upside	GRI Fair Value	GRI Upside
Bayesian DCF	Intrinsic	$13.58	-65.5%	$3.99	+93.7%
Earnings Power Value	Intrinsic	$20.74	-54.4%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$13.69	-65.2%	$0.05	-97.9%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for GPCR vs GRI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GPCR vs GRI — Which Stock Is More Undervalued?

GPCR scores higher with a 4.1/10 quality rating vs GRI's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Structure Therapeutics Inc. (GPCR) and GRI Bio, Inc. (GRI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GPCR currently trades at $39.34 with a QOC of 4.1/10, while GRI trades at $2.06 with a QOC of 3.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).